Journal profile · PERIPHERAL VASCULAR DISEASE
Journal of Clinical Hypertension
ISSN 1524-6175 · eISSN 1751-7176 · Wiley-Blackwell Publishing Ltd · UNITED STATES · Monthly · Founded 1999
Journal of Clinical Hypertension: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.92; fully open access; APC about USD 4,400; median 81 days to acceptance (97 articles, last 24 months); acceptance rate 26% (journal website); 233 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Clinical Hypertension is published by Wiley-Blackwell Publishing Ltd and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Blood Pressure and Hypertension Studies, Cardiovascular Health and Disease Prevention and Heart Rate Variability and Autonomic Control, together about 50% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Clinical Hypertension is a peer-reviewed, Gold Open Access (OA) monthly publication that serves internists, cardiologists, nephrologists, endocrinologists, hypertension specialists, primary care practitioners, pharmacists and all professionals interested in hypertension by providing objective, up-to-date information and practical recommendations on the full range of clinical aspects of hypertension. Commentaries and columns by experts in the field provide further insights into our original research articles as well as on major articles published elsewhere. Major guidelines for the management of hypertension are also an important feature of the Journal. For questions and information on submissions, contact: Editorial Assistant jcheditorial@wiley.com
From the journal's Aims & Scope
Research area (LetPub): PERIPHERAL VASCULAR DISEASE
Editor-in-chief Ji-Guang WangPublisher website
Editorial board by country: 4 in mainland China (about 40%); most named Mainland China 4, Hong Kong, China 1, United States 1, Japan 1, South Korea 1 (10 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Blood Pressure and Hypertension StudiesMedicine32.8%
- Cardiovascular Health and Disease PreventionMedicine8.9%
- Heart Rate Variability and Autonomic ControlMedicine8.3%
- Sodium Intake and HealthNursing8.2%
- Hormonal Regulation and HypertensionMedicine6.9%
- Nutritional Studies and DietMedicine4.3%
- Cardiovascular Syncope and Autonomic DisordersMedicine3.3%
- Hemodynamic Monitoring and TherapyMedicine2.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Peripheral Vascular Disease | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Peripheral Vascular Disease | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Peripheral Vascular Disease | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseCINAHLCurrent ContentsPublisher website
Other: EBSCO
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.92LetPub ·
- Impact factor (publisher)
- 2.9Publisher website ·
- Impact factor (publisher) 2025
- 2.9Publisher website ·
- CiteScore 2026-06
- 4.4LetPub ·
- CiteScore (publisher)
- 4.4Publisher website ·
- CiteScore (publisher) 2025
- 4.4Publisher website ·
- SJR 2026-06
- 0.83LetPub ·
- SNIP 2026-06
- 0.97LetPub ·
- h-index
- 60LetPub ·
- h-index
- 108OpenAlex ·
- i10-index
- 2,238OpenAlex ·
- 2-year mean citedness
- 2.29OpenAlex ·
- Self-citation rate
- 3.4%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 170LetPub ·
- Articles per year (publisher) 2025
- 208Publisher website ·
- Downloads per year (publisher) 2025
- 1,088,308Publisher website ·
Articles by year OpenAlex count · 5,463 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 178 | 178 | 51 |
| 2025 | 233 | 233 | 438 |
| 2024 | 210 | 210 | 935 |
| 2023 | 148 | 148 | 1,527 |
| 2022 | 219 | 219 | 2,339 |
| 2021 | 257 | 257 | 4,070 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
81 daysMedian, submission to acceptance · P25–P75 51 days – 121 days
- Acceptance to online
- median 22 days (97 articles)
- Submission to online
- median 112 days
- Sample
- 97 articles with submission and acceptance dates (447 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Acceptance rate (publisher)
- 26%Publisher website ·
- Acceptance rate (publisher) 2025
- 26%Publisher website ·
- Submission to first decision
- 8 daysPublisher website ·
- Submission to first decision 2025
- 8 daysPublisher website ·
- Submission to acceptance 2025
- 74 daysPublisher website ·
- Acceptance to publication 2025
- 22 daysPublisher website ·
- Submission to publication (journal-reported)
- about 14 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 4,400 / GBP 3,200 / EUR 3,890 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 4,000 / EUR 3,540 / GBP 3,200 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Reference style
- AMA
- First submission
- Free format: the journal's layout is not required
Article types accepted13, with length limits
- clinical trialClinical Trial: Articles that report the main results of a randomized controlled trial about 2,500–4,000 words and 25–50 references maximum (about 10–20 pages t…Length not stated
- commentaryCommentary (by invitation only): Commentaries invited to accompany an accepted article to allow the expert who is invited to write the commentary an opportunity…Length not stated
- editorialerences maximum (about 10 pages total). Editorial (by invitation only): No more than 1,500 words and 25 references maximum (no abstract; about 4 pages totalmain text ≤ 1,500 words
- guidelinesGuidelines: Full documents or executive summaries of national, regional and international guidelines without limit of words, references or pages.Length not stated
- invited reviewInvited Review: Commissioned review articles on a topical issue in the field of hypertension. No more than 2,500 words and 25–40 references maximum (about 10 pa…Length not stated
- letter to the editorLetter to the Editor: Letters in response to a published article in JCH. No more than 600 words (no abstract).Length not stated
- meta-analysisMeta-Analysis: A meta-analytical article that should better be based on systematic review on a topical issue in the field of hypertension. No more than 2,500 wo…Length not stated
- opinionOpinion: Focused opinions on areas of hypertension that offer new perspectives or challenge established thinking. An abstract is not required, 1,500 words or le…Length not stated
- original articleOriginal Article:A report of research work or analyses conducted by the author(s) of the manuscript. About 2,500–4,000 words and 25–50 references maximum (about…Length not stated
- replyReply (by invitation only): Letters in response to a Letter to the Editor that has been accepted for publication. No more than 600 words (no abstract).Length not stated
- reviewReview: This should be a balanced evaluation of the literature pertaining to a topic of interest in the field of hypertension. No more than 2,500 words and 25–4…Length not stated
- short research articleShort Research Article: Brief reports of data from original research or analysis should include an unstructured abstract (no more than 150 words), 1,500 words o…Length not stated
- study designStudy Design: Articles that describe the rationale and study design of a major clinical trial or a prospective registry or population-based study. No more than …Length not stated
Policy excerpts from the journal's websiteData availability, Publication ethics, Open access, Peer review, Plagiarism
- Data availability Expects Data Sharing
Data sharing expected Model summary
Journal of Clinical Hypertension expects that data supporting the results in the paper will be archived in an appropriate public repository. Authors are required to provide a data availability statement to describe the availability or the absence of shared data. When data have been shared, authors are required to include in their data availability statement a link to the repository they have used,…
Source ↗Publisher website ·- Publication ethics
COPE member Model summary
This journal follows the core practices of the Committee on Publication Ethics (COPE)
Source ↗Publisher website ·- Open access Open Access and Licenses
Continuous publication Model summary
If your paper is accepted, the author identified as the formal corresponding author will receive an email prompting them to log in to Author Services, where via the Wiley Author Licensing Service (WALS) they will be required to complete a copyright license agreement on behalf of all authors of the paper.
Source ↗Publisher website ·- Peer review Peer Review
Single-blind peer review Model summary
This journal operates under a single-blind peer review model. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements.
Source ↗Publisher website ·- Plagiarism
iThenticate plagiarism check Model summary
This journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1999
- ISSN
- 1524-6175
- Electronic ISSN
- 1751-7176
- Latest issue on the website
- Volume 28, Issue 9 (September 2026)
- Official links
FAQ
Frequently asked questions about Journal of Clinical Hypertension
What CAS zone is Journal of Clinical Hypertension in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Clinical Hypertension is in Zone 3 of Medicine, and in Zone 3 of the minor category Peripheral Vascular Disease. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Clinical Hypertension?
The latest impact factor listed by LetPub is 2.92; CiteScore 4.4, h-index 108.
How long does peer review take at Journal of Clinical Hypertension?
Based on the dates recorded on 97 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 81 days (interquartile range 51–121 days); authors report an average review time of 4–8 weeks; the journal's website gives an acceptance rate of 26% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Clinical Hypertension?
According to the journal's author guidelines: Reference style: AMA; First submission: Free format: the journal's layout is not required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Clinical Hypertension based?
Of the 10 board members whose country the journal's board page names, 4 (about 40%) are in mainland China; the countries named most often are Mainland China (4), Hong Kong, China (1) and United States (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Clinical Hypertension?
According to LetPub and DOAJ records, Journal of Clinical Hypertension is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, PubMed, Embase, CINAHL and Current Contents; that list has not been checked against each database.
Is Journal of Clinical Hypertension open access, and what is the APC?
Journal of Clinical Hypertension is a fully open-access journal. APC about USD 4,400.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .